On the Leading Edge of Treatment for Advanced Heart Failure & Transplantation
At the forefront of cardiac care and research for over 40 years, the Montefiore Einstein Heart Failure Program is defined by exceptional outcomes, technological innovation and clinical excellence. We performed the world’s first HIV+ to HIV+ heart transplant and as the fastest growing program in Heart Transplantation with among the Highest National Survival Rates, we continue to take an integrated approach to provide comprehensive, individualized treatment plans for even the highest-risk patients with advanced heart disease. This collaborative approach also facilitates thorough dialogue regarding each patient’s medical history, lifestyle and individual needs, resulting in the best treatment outcomes. We're ranked in the top 1% of all hospitals in the nation for Cardiology, Heart & Vascular Surgery according to U.S. News & World Report.
Comprehensive, Collaborative Care
The Montefiore Einstein Heart Failure and transplantation Program comprises a cross-collaborative team of cardiologists, cardiothoracic surgeons and cardiac imaging specialists who contribute to each patient’s treatment plan in order to arrive at the most effective solutions, from medical therapy to transplant. We treat patients across all areas of care for heart failure, depending on their type and stage of disease.
Our Program considers treatment options according to the stage and severity of heart failure, offering medical, surgical, and mechanical circulatory support treatment options:
Your Heart Failure & Transplant Team
Ibrahim Abdullah, MD
Mario J. Garcia, MD
Daniel Goldstein, MD
Ulrich P. Jorde, MD
The Montefiore Einstein Heart Failure and transplantation Program comprises a multidisciplinary team of cardiologists, cardiothoracic surgeons, cardiac imaging specialists, and other specialists who contribute to each patient’s treatment plan in order to provide the most effective solutions, from medical therapy to transplantation. We treat patients across all types of heart failure according to, depending on their condition and stage of disease, with the ultimate goal of improving quality of life.
